Bradycardia as a Marker of Chronic Cocaine Use: A Novel Cardiovascular Finding by Sharma, Jyoti et al.
Bradycardia as a Marker of Chronic Cocaine Use: A Novel 
Cardiovascular Finding
Jyoti Sharma, M.D.a, Nuvan Rathnayakab, Charles Green, Ph.D.b, F. Gerard Moeller, M.D.c, 
Joy M. Schmitz, Ph.D.b, Daniel Shohamd, and Anne Hamilton Dougherty, M.D., FHRSe
aPiedmont Heart Institute, Atlanta, Georgia
bDepartment of Psychiatry, Center for Neurobehavioral Research on Addictions, University of 
Texas Health Science Center at Houston
cDepartment of Psychiatry, VCU Institute on Drug and Alcohol Studies, Virginia Commonwealth 
University School of Medicine
dUniversity of Texas at Houston Medical School
eDivision of Cardiology, Department of Medicine, University of Texas Health Science Center at 
Houston
Abstract
Background—Few studies have examined the effects of chronic cocaine use on the resting 
surface electrocardiogram (ECG) between exposures to cocaine.
Methods—12-lead ECGs from 97 treatment-seeking cocaine-dependent subjects were compared 
to ECG parameters from 8513 non-cocaine-using control subjects from the Atherosclerosis Risk in 
Communities study.
Results—After matching and adjusting for relevant covariates, cocaine use demonstrated large 
and statistically reliable effects on early repolarization, bradycardia, severe bradycardia, and heart 
rate. Current cocaine dependence corresponds to an increased odds of demonstrating early 
repolarization by a factor of 4.92 and increased odds of bradycardia and severe bradycardia by 
factors 3.02 and 5.11, respectively.
Conclusion—This study demonstrates the novel finding that long-lasting effects of cocaine use 
on both the cardiac conduction and the autonomic nervous system pose a risk of adverse 
cardiovascular events between episodes of cocaine use, and that bradycardia is a marker of chronic 
cocaine use.
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Introduction
Cocaine is a powerfully addictive central nervous system stimulant that is commonly used in 
the United Sates. The National Institute on Drug Abuse (NIDA) reports that in 2009, 4.8 
million Americans age 12 and older used cocaine in any form and 1.0 million had used crack 
cocaine at least once in the year prior to being surveyed1. Cocaine is known to play a causal 
role in several cardiovascular complications including acute coronary syndromes, 
accelerated atherosclerosis, aortic dissection, endocarditis, myocardial dysfunction, and 
dysrhythmias2,3.
Several cardiac dysrhythmias related to cocaine have been documented3. These include 
sinus tachycardia, supraventricular tachycardia, bundle branch block, complete heart block, 
ventricular tachycardia, ventricular fibrillation, asystole, and torsades de pointes. Most 
studies have focused on the association between acute cocaine use and the occurrence of 
ventricular arrhythmias (such as monomorphic VT) and QT prolongation4–8. Dysrhythmias 
associated with acute cocaine use may be related to sodium and potassium channel 
blockade, thus prolonging both conduction and repolarization3. In addition to its effects on 
sodium channels, cocaine enhances sympathetic drive, which increases ventricular 
irritability and promotes ventricular tachyarrhythmias. However, the exact mechanism of 
action and arrhythmogenic potential of chronic cocaine use has not been well documented in 
human electrophysiologic studies9.
To date, there has been one smaller human study that focused specifically on the relationship 
between chronic cocaine use and sinus bradycardia adjusting for age and gender10. That 
study found that habitual cocaine use was associated with a significantly increased incidence 
of sinus bradycardia when compared with controls. Whereas bradycardia may produce 
clinical symptoms, such as fatigue that might contribute to withdrawal symptoms, it is also a 
known risk factor for the development of certain types of ventricular arrhythmias11,12.
Sinus bradycardia has also been associated with the common electrocardiographic finding of 
early repolarization13,14. Early repolarization affects 1–5% of the general population and 
was long considered to be a benign condition13,14. However, recent clinical studies have 
shown that patients with this type of ECG pattern are at increased risk of ventricular 
fibrillation (VF)15,16.
The objective of this study was to examine resting electrocardiograms of chronic cocaine 
users for abnormalities, and to compare these ECG parameters to those of non-drug using 
controls. Accordingly, the analysis was restricted to subjects without cardiac symptoms and 
ECGs obtained in the absence of acute cocaine intoxication. The relationship between 
cocaine use, sinus bradycardia, and early repolarization in cocaine users was also examined.
Methods
Patient Population
We retrospectively reviewed the ECG recordings taken from August 2006 through 
December 2010 in 244 cocaine-dependent subjects. These ECGs were collected as part of a 
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screening process prior to entry into research studies within the Center for Neurobehavioral 
Research on Addictions at the University of Texas Health Center at Houston. Patients 
showed no symptoms of cocaine intoxication at the time of ECG recording. All patients 
were screened by licensed clinical counselors for symptoms of cocaine dependence as 
defined by the Diagnostic and Statistical Manual of Mental Disorders version IV text 
revision (DSM-IV-TR) using the Structured Clinical Interview for the DSM Disorders 
(SCID)17. Subjects who met DSM-IV-TR criteria for cocaine dependence in between the 
ages of 45–60 years old were included. Those with concomitant illicit opiate, 
benzodiazepine, amphetamine or methamphetamine use, as verified by serial urine 
toxicology testing, were excluded. Concomitant marijuana and alcohol use was not 
exclusionary as the majority of treatment-seeking cocaine dependent patients also use these 
drugs. Cocaine dependent subjects who had documented previous myocardial infarction, 
diabetes, or medications (including antihypertensive medications) that could affect the 
central or peripheral nervous system were also excluded. This retrospective chart review 
evaluated existing data collected as part of the screening protocol that was reviewed and 
approved by the Committee for the Protection of Human Subjects (CPHS) of the University 
of Texas Medical School, Houston.
In addition, de-identified electrocardiographic data from 8513 control subjects were 
reviewed. This data was provided from the Atherosclerosis Risk in Communities (ARIC) 
study funded by the National Heart Lung and Blood Institute (NHLBI) at the National 
Institutes of Health. Subjects were randomly selected from the 15,732 subjects in the dataset 
to approximate the age, gender, race distribution of the cocaine dependent subjects. In 
addition, subjects coded in the NHLBI dataset as having a previous myocardial infarction, 
diabetes, and medications for hypertension were excluded.
Cocaine-dependent subjects ranged in age from 20–60 and control subjects in the ARIC 
dataset ranged in age from 45–65. To avoid bias due to differences in age distribution 
between the cocaine and control subjects, primary analysis for the current study restricted 
the age range to subjects aged 45–6018. See Figure 1.
ECG Analysis
Standard 12-lead electrocardiograms were recorded at a speed of 25 mm/s and voltage of 10 
mm/mV in an outpatient psychiatric clinic setting. These ECGs were reviewed by two 
independent and experienced cardiologists. The following parameters were identified: heart 
rate, rhythm, PR interval in milliseconds (ms), QRS interval in milliseconds, QT interval in 
milliseconds, QT corrected interval in milliseconds, presence or absence of early 
repolarization, presence or absence of left ventricular hypertrophy (by Cornell and Estes 
criteria)19,20, and presence or absence of ST segment elevation consistent with Brugada 
criteria21,22. Sinus bradycardia was defined as a heart rate < 60 beats per minute (bpm). 
Severe bradycardia was defined as < 50 bpm. Early repolarization was defined as an 
elevation of the J point ≥1mm compared to the baseline accompanied by a positive T wave 
with upward concavity in at least two adjacent leads13,14.
Of note, the ARIC database did not include QT or QTc data for approximately 14,000 
subjects. Therefore, QT and QTc data is not reported for control subjects from this database. 
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However, normal QT and QTc measurements in the general population are extensively 
described in the literature22,23. In general, a normal QTc measurement is considered to be 
acceptable if it is less than or equal to 440 ms.
Measurements of Cocaine Use
Cocaine dependent subjects provided information regarding duration of cocaine use (years) 
and frequency of recent use (days in past 30). They also underwent a urine drug screen for 
the cocaine metabolite benzoylecgonine (BE). Self-reported cocaine use was not available 
for eight cocaine dependent subjects. Urine drug screen results were not available on 35 
subjects.
Statistical Methods
A Student’s t-test was used to compare continuous variables and Chi-Square analysis or a 
Fisher’s exact test was used to compare categorical variables. P values of < 0.05 were 
considered statistically significant.
Following Stuart and Rubin’s recommendation for “doubly robust” estimation18, the current 
protocol implemented matching followed by covariate adjusted estimates for the effect of 
cocaine use on cardiac variables. Propensity score matching reduced bias by matching 
control subjects and cocaine subjects on baseline covariates. Six different matching 
algorithms (exact, nearest neighbor, optimal, full matching, genetic matching, and coarsened 
exact matching) evaluated the balance across cases and controls on the following covariates: 
age, gender, ethnicity, former drinker, current drinker, former smoker, current smoker, 
education level, total cholesterol level, triglycerides, and BMI. Inclusion of grand mean 
single imputation with the addition of a missingness vector for salient covariates addressed 
missing observations. Inspection of the absolute standardized differences in means between 
the matched control and matched treatment group for each covariate suggested that full 
matching minimized differences across groups as well as extreme values for all covariates. 
Regression analysis on the matched samples, with a model including the same covariates 
used for matching, adjusted for any remaining covariate differences. Regression analysis of 
the early repolarization outcome also adjusted for heart rate.
Results
Of the 244 cocaine users’ electrocardiograms reviewed, 93 patients (38%) were excluded 
due to age outside the range of 45–60 years old, and 54 patients (22%) were excluded due to 
concomitant medical or psychiatric history. 97 cocaine-dependent subjects and 8513 control 
subjects were included in the final analysis. The baseline characteristics and 
electrocardiographic data of all 8610 patients are presented in Table 1. The two groups 
differed significantly on gender or ethnicity (p =<0.0001 and p=<0.0001, respectively). 
Mean age among cocaine-dependent subjects was 49.5 ± 3.9 years and was 51.8 ± 4.5 years 
in control subjects (p < 0.0001). The mean QT interval of female cocaine users was 417.3 
±37.7 ms and mean QT interval of male cocaine users was 420.5 ± 33.1 ms. (QT corrected 
(QTc) interval was 420.6.1 ±16.3 ms in female cocaine users and 409.8 ± 14.8 ms in male 
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cocaine users. 1 % of both controls and cocaine users’ ECGs met criteria for left ventricular 
hypertrophy. No QRS or ST segment changes were consistent with the Brugada syndrome.
ECG measured heart rates were significantly lower in cocaine-dependent subjects than in 
controls (Figure 2). Mean heart rate was 58.9 ± 9.8 bpm for cocaine users and 66.2 ± 9.6 
bpm for controls (p <0.0001). The proportion of subjects with heart rates below 60 bpm was 
significantly higher for cocaine-dependent subjects, with 59.8% of cocaine-dependent 
subjects having bradycardia, compared to 23.9% of controls (p < 0.0001). Likewise, the 
proportion of cocaine dependent subjects with severe bradycardia (ECG heart rate ≤ 50 
bpm) was significantly higher in cocaine-dependent subjects (22.7%) compared to controls 
(3.5%) (p <0.0001).
Within cocaine-dependent subjects, 27.8% of subjects had early repolarization. Rates of 
early repolarization tended to be higher in cocaine-dependent subjects with bradycardia 
(34.5%) compared to cocaine-dependent subjects without bradycardia (18.0%) (Pearson 
Chi-square =3.17, p = 0.075). Differences in rates of early repolarization were even stronger 
in cocaine-dependent subjects with severe bradycardia (45.5%) compared to those without 
severe bradycardia (22.7%) (p = 0.036). Of those with early repolarization findings, criteria 
were evident in the lateral leads in 14 (52%) and in inferior leads in 2 (7%). Global criteria 
(inferior, lateral and right precordial leads) were evident in 21 (41%).
The adjusted effect size estimates of early repolarization, bradycardia, and severe 
bradycardia for cases relative to controls are listed in Table 2. After matching and adjusting 
for relevant covariates, cocaine use demonstrated large and statistically reliable effects on 
early repolarization, bradycardia, severe bradycardia, and heart rate. Current cocaine 
dependence corresponds to an increased odds of demonstrating early repolarization by a 
factor of 4.92 (95% CI 2.73–8.87), adjusting for heart rate and by a factor of 5.58 when not 
adjusted for heart rate (95% CI 3.13–9.94). Cocaine dependence is associated with an 
increase in the odds of bradycardia and severe bradycardia by factors 3.02 (CI 1.95–4.66) 
and 5.11 (95% CI 2.95–8.84), respectively. Finally, cocaine dependence is associated with a 
decrease of 5.84 bpm in resting heart rate (95% CI 7.85–3.82). Finally, we re-ran the 
analyses on the total cocaine sample including the full age range (20 – 60 years old). 
Although the matching procedure failed to produce adequate covariate balance due to the 
disparity in age range between the groups, the same set of results obtained, with cocaine 
dependence associated with significant effects on heart rate, bradycardia, severe bradycardia 
and early repolarization. Since the matching procedure performed poorly for the full age 
range analysis (cocaine group: ages 20–60), the age restricted analysis (cocaine group: ages 
45–60) reported above provides the most unbiased estimates.
There was no relationship between presence of the cocaine metabolite BE in urine and heart 
rate. Cocaine dependent subjects who were positive for BE had a mean heart rate of 58.8 ± 
10.3 bpm, while those were negative for the metabolite had a mean heart rate of 58.6 ± 8.5 
bpm (t = 0.07, p = 0.9477). Likewise, BE status was not related to bradycardia, severe 
bradycardia, or early repolarization. There was a significant association between years of 
cocaine use and presence of severe bradycardia, even after controlling for age. Subjects with 
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severe bradycardia reported more years of cocaine use (20.1 years) compared to subjects 
without severe bradycardia (15.4 years), p= 0.011.
Discussion
Overall, the main findings of our study are threefold. First, we found that ECG measured 
resting heart rate is significantly lower in chronic cocaine users compared to control 
subjects. Secondly, cocaine users had much higher odds of ECG changes consistent with 
early repolarization compared to controls (see figure 3 for sample ECG tracing). Though 
higher rates of early repolarization were found in cocaine users with bradycardia, regression 
analysis shows that cocaine-dependent subjects have elevated odds of early repolarization 
relative to matched controls even after controlling for heart rate. Finally, our data shows that 
severity of bradycardia is associated with greater length of cocaine use, but not related to 
recency of cocaine use as measured by urine BE (urine BE will typically be positive 48 
hours after cocaine use, but has been shown to detect use up to 88 hours prior24).
To date, there have been two other human studies examining the relationship between 
chronic cocaine use and heart rate between episodes of use10,25,26. Comparing 54 cocaine 
users to 54 gender-matched controls admitted to the ED, Hollander et al. found that cocaine 
users had higher heart rates25. In contrast, Fontaine et al. compared 160 habitual cocaine 
users to 160 age and gender-matched controls admitted to the ER, finding that cocaine users 
had higher rates of sinus bradycardia relative to controls10. One preclinical study found that 
rodents treated with intraperitoneal cocaine 20mg/kg/day for 14 days could not mount an 
appropriate tachycardic response to acute blood loss and hemorrhagic shock when compared 
to controls27. In addition, chronic cocaine use can blunt the body’s normal adrenergic 
response to stress and has been linked to decreased survival27. Cocaine’s potent effect on the 
autonomic nervous system likely contributes to the high rates of sinus bradycardia seen in 
both studies. During acute use, cocaine blocks the presynaptic reuptake of norepinephrine 
and dopamine, producing an excess of these neurotransmitters at the postsynaptic receptor 
site, acting as a sympathomimetic agent3. Previous studies have shown that continuous 
exposure to catecholamines leads to β-adrenergic receptor desensitization28,29. Here, we 
define desensitization as a diminishing biologic response during continuous exposure to a 
stimulus.
Schwinn et al30 showed that cardiopulmonary bypass, a known powerful stimulant of 
endogenous catecholamine release, leads not only to myocardial β-adrenergic receptor 
desensitization, but also to a decrease in receptor density. We hypothesize that a similar 
mechanism of action explains why over half of cocaine users in our study are bradycardic, 
and why severity of bradycardia is associated with length of cocaine use. It is likely that 
repeated exposure to cocaine eventually leads to myocardial β-adrenergic receptor down-
regulation, and thus slower heart rates. Our data also shows that heart rate down-regulation, 
and presumably β-receptor down-regulation, appear to outlast the urine BE test, however the 
time course of recovery remains to be determined. Another possible mechanism of action is 
the myopathy and diffuse myocardial necrosis associated with chronic cocaine abuse26, 
which could occur throughout the conduction system to produce the observed sinus 
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bradycardia. It is possible that symptoms of bradycardia during withdrawal contribute to the 
addictive nature of cocaine.
Two prior studies31,32 showed that cocaine dependent subjects who were admitted to the 
hospital showed a significant increase in heart rate over the first week after abstaining from 
cocaine use in a small number of individuals. The results of these studies suggest that longer 
term abstinence from cocaine might ameliorate bradycardia. This has implications for 
treatment research as resolving bradycardia could be pursued as a diagnostic marker of long 
term abstinence.
Early repolarization has been referred to as a “J wave syndrome linked to abnormalities of 
the transient outward current (Ito), seen in ventricular epicardium. While initially thought to 
represent a benign ECG finding, increasing evidence indicates that early repolarization can 
be associated with increased risk for VF and sudden cardiac death15,16. The ECG leads 
involved, magnitude of the J wave, and degree of ST elevation appear to be key 
determinants of whether or not early repolarization will lead to a lethal rhythm. Antzelevitch 
et al33 suggested that patients with type 3 early repolarization, those with global early 
repolarization as seen in the lateral, inferior, and right precordial leads, are at the highest risk 
for ventricular dysrhythmias. In this study, over 40% of all cocaine users with early 
repolarization presented with ECGs consistent with type 3 early repolarization.
While the prevalence of early repolarization in the general population varies between 1–
5%13,14, some specific populations have been shown to have higher rates of this ECG 
finding. It has more commonly been seen in men and young persons (up to 27.5%)34. Earlier 
studies intimated that early repolarization was more likely to be seen in African Americans, 
but contemporary studies have challenged this concept34. One study of 56 active cocaine 
users that presented to the emergency room for treatment of chest pain were found to have 
high rates of early repolarization, between 32–41%, on initial ECG25. Our study 
corroborates this finding, demonstrating a slightly more modest effect in the subacute 
setting.
The extent of ST-segment elevation as seen in early repolarization is affected by several 
well documented factors, including heart rate, medications, and autonomic influence. 
Slowing of the heart rate increases ST-segment elevation, as seen with β receptor blockade, 
while an increase in heart rate, as seen after isoproterenol administration or during exercise, 
often eliminates the ST-segment elevation34. We suspect that a large percentage of cocaine 
users were bradycardic due to myocardial β-adrenergic receptor desensitization and down-
regulation, resulting in blunted adrenergic effect. This is the most likely explanation for our 
study’s finding of increasing rates of early repolarization among those cocaine abusers with 
more profound bradycardia. Of note, only 1% of cocaine users met criteria for left 
ventricular hypertrophy, so this did not likely contribute to our study’s finding of high rates 
of early repolarization.
Cocaine’s effects on neurotransmitters and sodium channel blocking properties are well 
known. Our study did not show an increase in either QRS or QT intervals beyond accepted 
norms in these chronic cocaine users. However, the effects on sodium channels may 
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contribute to the high rates of early repolarization seen. Sodium channel blockers have been 
reported to increase ST-segment elevation in patients with early repolarization34.
Our study has several limitations. First, the observational nature of this retrospective study 
restricts causal inference. Secondly, although 244 number cocaine abusers’ 
electrocardiograms were screened, only 97 patients were included in our analysis, due to 
exclusion of subjects with concomitant drug use, cardiac history, or age that did not overlap 
with the control subjects. The effect of polysubstance abuse deserves further investigation. 
Future research should focus on recruiting larger numbers of patients with prospective ECG 
evaluation. There was also the smaller issue of urine drug screen results not being available 
for 10 patients. The coarse nature of urine drug screen results and underreporting in self-
report measures35 prevents more fine-grained assessment of the effect of time since last use. 
It should also be noted that the majority of our cocaine subjects were African American 
men. Future studies should focus on a more diverse subject population to determine whether 
our results can be extended to other ethnicities and to women. Finally, we were not able to 
obtain long term follow up regarding major adverse cardiac events, specifically on sudden 
cardiac death. It would be important to know if patients with these ECG changes did have 
higher rates of ventricular arrhythmias, or if they have a relatively benign course as some 
population studies of early repolarization have suggested. Future studies should focus on 
assessing the long-term cardiac outcomes of chronic cocaine users and assessing whether 
abstinence from cocaine improves severity of bradycardia.
The results of this study demonstrate the novel finding that severe bradycardia may be a 
marker of chronic cocaine use. Additionally, within cocaine users, severity of bradycardia is 
linked to higher rates of early repolarization, potentially increasing risk of sudden cardiac 
death in between episodes of acute cocaine use. Finally, severity of bradycardia is related to 
chronicity of cocaine use.
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Appendix A
Analysis including all cocaine subjects aged 20 to 60.
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Table 1
Demographic and ECG characteristics at Baseline by Groupa
Cocaine-Dependent Subjects (n= 97) Controls (n= 8513) p-value
Age, mean (SD), years 49.5 (3.9) 51.8 (4.5) < 0.0001
Male, No. (%) 83 (85.6) 3706 (45.5) < 0.0001
Female, No. (%) 14 (14.4) 4447 (54.5) < 0.0001
African American Race, No. (%) 73 (78.4) 1753 (21.5) < 0.0001
ECG measured heart rate, mean (SD), bpm 58.9 (9.8) 66.2 (9.6) < 0.0001
Bradycardia, No. (%) 58 (59.8) 1940 (23.9) < 0.0001
Severe Bradycardia (HR ≤ 50), No. (%) 22 (22.7) 286 (3.5) < 0.0001
Early repolarization, No. (%) 27 (27.8) 109 (1.28) < 0.0001
QT interval-Female, mean (SD), ms 417.3 (37.7) -- NA
QT interval-Male, mean (SD), ms 420.5 (33.1) -- NA
QTc interval-Female, mean (SD), ms 420.6 (16.3) -- NA
QTc interval-Male, mean (SD), ms 409.8 (14.8) -- NA
Left Ventricular Hypertrophy (Cornell criteria), No. (%) 1 (1.0) 76 (1.0) 0.9494
Years of Cocaine Use, mean (SD) [range] 16.5 (7.7) [<1 to 33] NA
Days of Cocaine Use in Last 30 days, mean (SD) [range] 16.3 (9.1) [1 to 30] NA
a
These are the unweighted statistics obtained prior to matching. The analysis used the weighted statistics from the matching analysis. The weighted 
statistics after matching are available upon request.
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Table 2
Adjusted effect size estimates for cases relative to controls
Odds Ratio 95% LCL 95% UCL p-value
Early 4.92 2.73 8.87 ≤0.0001
Repolarization, adjusted for heart rate
Early Repolarization, unadjusted for heart rate 5.58 3.13 9.94 ≤0.0001
Bradycardia 3.02 1.95 4.66 ≤0.0001
Severe Bradycardia 5.11 2.95 8.84 ≤ 0.0001
B weight 95% LCL 95% UCL p-value
Heart Rate −5.84 −7.85 −3.82 ≤0.0001
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